Skip to main content
Premium Trial:

Request an Annual Quote

Japan s Radiological Institute Licenses Rosetta s Resolver

NEW YORK, April 29-Rosetta, a Merck subsidiary, said today that it had licensed its Resolver gene expression analysis system to Japan's National Institute of Radiological Sciences.

 

The company did not reveal financial specifics.

 

Resolver is a bioinformatics system for use with DNA microarrays. It is marketed by Agilent Technologies

 

NIRS will use the Rosetta software for research into radiation therapy of malignancies and radiation-based disease diagnostics.

 

This is Rosetta Biosoftware's first license in Asia Pacific.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.